Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and various squamous an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEN-866

Snippet

Sponsor: Tarveda Therapeutics | Conditions: Carcinoma, Endometrial Adenocarcinoma | Phase 1, Phase 2 | Status: UNKNOWN